79 related articles for article (PubMed ID: 24037217)
1. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
[TBL] [Abstract][Full Text] [Related]
2. Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin.
Czeczok TW; Stashek KM; Maxwell JE; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):94-100. PubMed ID: 29420353
[TBL] [Abstract][Full Text] [Related]
3. IMMUNOHISTOCHEMICAL MARKERS AND SPECT/CT SOMATOSTATIN-RECEPTOR (99MTC-TEKTROTYD) UPTAKE IN WELL AND MODERATELY DIFFERENTIATED NEUROENDOCRINE TUMORS.
Bădan MI; Piciu D
Acta Endocrinol (Buchar); 2022; 18(4):523-530. PubMed ID: 37152876
[TBL] [Abstract][Full Text] [Related]
4. DOG1 expression in neuroendocrine neoplasms: Potential applications and diagnostic pitfalls.
Marando A; Di Blasi E; Tucci F; Aquilano MC; Bonoldi E
Pathol Res Pract; 2023 Aug; 248():154623. PubMed ID: 37331184
[TBL] [Abstract][Full Text] [Related]
5. Divergent expression of DCLK1 in gastrointestinal neuroendocrine tumors and primary hepatic, gallbladder, and pancreatic neuroendocrine tumors.
Fan M; Yan H; Gou M; Qian N; Dai G
Int J Clin Exp Pathol; 2020; 13(9):2249-2258. PubMed ID: 33042329
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and diagnostic challenges of small cluster pattern appendiceal neuroendocrine tumors.
Gertsen B; Arshi J; Li RX; Findeis-Hosey JJ; Huber AR; Hao Y
Ann Diagn Pathol; 2024 Apr; 69():152250. PubMed ID: 38142627
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ß-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association With Endometrioid Type II Stem Cell Outgrowths in the Fallopian Tube.
Xu J; McGregor SM; Park KJ; Weisman PS
Int J Gynecol Pathol; 2024 Mar; 43(2):145-148. PubMed ID: 37922952
[No Abstract] [Full Text] [Related]
8. Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm: A Clinical Challenge.
Rossi RE; Corti F; Pusceddu S; Milione M; Coppa J; Masoni B; Oldani S; Sabella G; Cafaro P; Repici A
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685605
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors.
Soukup J; Manethova M; Stejskal V; Hornychova H; Cesak T; Netuka D; Ryska A; Gabalec F
Endocr Pathol; 2023 Sep; 34(3):333-341. PubMed ID: 37552455
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies.
Sánchez ML; Rodríguez FD; Coveñas R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373115
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup.
Juhlin CC; Zedenius J; Höög A
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565339
[TBL] [Abstract][Full Text] [Related]
12. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features.
Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Klöppel G
Virchows Arch; 2022 Feb; 480(2):359-368. PubMed ID: 34499237
[TBL] [Abstract][Full Text] [Related]
13. Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask.
Albertelli M; Grillo F; Lo Calzo F; Puliani G; Rainone C; Colao AAL; Faggiano A;
Front Endocrinol (Lausanne); 2021; 12():680305. PubMed ID: 33967966
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.
Bocchini M; Nicolini F; Severi S; Bongiovanni A; Ibrahim T; Simonetti G; Grassi I; Mazza M
Front Oncol; 2020; 10():831. PubMed ID: 32537434
[TBL] [Abstract][Full Text] [Related]
15. A primary neuroendocrine tumor of the left ventricle presenting with diarrhea-an unusual experience and literature review.
Li C; Huang J; Yang X; Xia J; Xu G; Zheng H
Diagn Pathol; 2020 Apr; 15(1):32. PubMed ID: 32245475
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine Liver Metastasis-a Specific Set of Markers to Detect Primary Tumor Sites.
Selberherr A; Koperek O; Riss P; Scheuba C; Kaderli R; Perren A; Niederle B
Endocr Pathol; 2019 Mar; 30(1):31-34. PubMed ID: 30456697
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
Uccella S; La Rosa S; Volante M; Papotti M
Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
[TBL] [Abstract][Full Text] [Related]
18. Pathology of Neuroendocrine Tumours of the Female Genital Tract.
Howitt BE; Kelly P; McCluggage WG
Curr Oncol Rep; 2017 Sep; 19(9):59. PubMed ID: 28735441
[TBL] [Abstract][Full Text] [Related]
19. Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.
La Rosa S; Sessa F; Uccella S
Endocr Pathol; 2016 Dec; 27(4):284-311. PubMed ID: 27169712
[TBL] [Abstract][Full Text] [Related]
20. High-grade poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: from morphology to proliferation and back.
La Rosa S; Sessa F
Endocr Pathol; 2014 Jun; 25(2):193-8. PubMed ID: 24715269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
